A Possible Option in Opioid-Related Harm Reduction Carlat Reports

A Possible Option in Opioid-Related Harm Reduction

The Carlat Addiction Treatment Report, Volume 8, Number 5, July 2020
https://www.thecarlatreport.com/newsletter-issue/catr8n5/

From The Carlat Addiction Treatment Report, July 2020, Opioid Use Disorder Treatment

Issue Links: Learning Objectives | Editorial Information

Topics: Harm reduction | Heroin | Opioid epidemic | Opioid Use Disorder | Pharmacology

Greg Sazima, MD

Dr. Sazima has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Medications are the mainstay of treatment for opioid use disorder (OUD), but what if patients decline buprenorphine, injectable naltrexone, and methadone? In this randomized trial, authors compared hydromorphone (Dilaudid) with diacetylmorphine (the active ingredient in heroin) among patients who reported injecting heroin.

You can't view details of this content, please login or buy subscription here